Jean-François Nicolas is an expert in Dermatology at Centre Hospitalier Lyon Sud (France). As of September 2026, ScienceLeadR ranks Jean-François Nicolas in the top 1% of experts worldwide for Dermatitis and Hypersensitivity. Jean-François Nicolas has authored 586 publications, the most recent in 2025, and is an investigator in 7 clinical trials. SLR score: 1,651 (community average: 125). How the SLR is computed.

LeadR Profile

Jean-François Nicolas Centre Hospitalier Lyon Sud France
1 651 ScienceLeadR Reputation 1651
Network Map

Dermatology

Subspecialties: Immunology - Infectiology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2025

Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Skin's molecular signature may help guide treatment of complex inflammatory skin diseases.
PMID 40411182 — skin, skin diseases, therapeutics
J Eur Acad Dermatol Venereol20250
Urocanase-Positive Skin-Resident Bacteria Metabolize cis-Urocanic Acid and in Turn Reduce the Immunosuppressive Properties of UVR.
PMID 40373957 — skin, dinitrofluorobenzene, urocanate hydratase, immunity, urocanic acid, immunosuppression therapy, bacteria, dermatology
J Invest Dermatol20250
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19.
PMID 39896810 — cytokines, cells, antibodies, lymphopenia, adaptive immunity, recycling, cytokine release syndrome, covid-19, plasma exchange, immune system diseases, immunity, therapeutics, plasma
Front Immunol20256
Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.
PMID 39295209 — pharmaceutical preparations, hypersensitivity, drug hypersensitivity, signs and symptoms, therapeutics
Allergy20243
Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.
PMID 39141587 — skin, cells, stevens-johnson syndrome, syphilis, pharmaceutical preparations, diagnosis, therapeutics, dermatology
Br J Dermatol20248

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 4
N/A 1
Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 6
Terminated 1

By type:

Interventional 7

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 5

Main Topics

LeadR Networks

Main global connection map